HansonYap
2021-03-26
Buy buy buy....
5 Stocks To Watch For March 26, 2021
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":356198104,"tweetId":"356198104","gmtCreate":1616762238408,"gmtModify":1634524138727,"author":{"id":3574851596973634,"idStr":"3574851596973634","authorId":3574851596973634,"authorIdStr":"3574851596973634","name":"HansonYap","avatar":"https://static.tigerbbs.com/3abe061f222c2562c2e3429d618bcbf3","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Buy buy buy.... </p></body></html>","htmlText":"<html><head></head><body><p>Buy buy buy.... </p></body></html>","text":"Buy buy buy....","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/356198104","repostId":2122420974,"repostType":4,"repost":{"id":"2122420974","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1616759314,"share":"https://www.laohu8.com/m/news/2122420974?lang=&edition=full","pubTime":"2021-03-26 19:48","market":"us","language":"en","title":"5 Stocks To Watch For March 26, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2122420974","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li><b>Progress Software Corp </b> (NASDAQ:PRGS) reported better-than-expected results for its first quarter and raised its FY21 guidance. Progress Software shares climbed 2.6% to $42.90 in the after-hours trading session.</li>\n <li><b>Pfizer Inc. </b> (NYSE:PFE) and <b>Eli Lilly and Company</b> (NYSE:LLY) disclosed that an expert panel of the U.S. Food and Drug Administration has rejected their application for their experimental drug for the treatment of osteoarthritis pain, citing safety risks and an inadequate plan to manage them. Pfizer also reported that it has started clinical trials of its COVID-19 vaccine with children. Pfizer shares slipped 0.1% to $35.66 in after-hours trading, while Eli Lilly shares fell 0.1% to $183.00 in the after-hours trading session.</li>\n</ul>\n<ul>\n <li><b>Co-Diagnostics Inc</b> (NASDAQ:CODX) reported downbeat earnings for its fourth quarter on Thursday. Co-Diagnostics shares dropped 7.1% to $11.26 in the after-hours trading session.</li>\n <li><b>Gan Ltd</b> (NASDAQ:GAN) reported weaker-than-expected results for its fourth quarter, but issued strong sales forecast. Gan shares declined 9% to $21.04 in after-hours trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For March 26, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For March 26, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-03-26 19:48</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li><b>Progress Software Corp </b> (NASDAQ:PRGS) reported better-than-expected results for its first quarter and raised its FY21 guidance. Progress Software shares climbed 2.6% to $42.90 in the after-hours trading session.</li>\n <li><b>Pfizer Inc. </b> (NYSE:PFE) and <b>Eli Lilly and Company</b> (NYSE:LLY) disclosed that an expert panel of the U.S. Food and Drug Administration has rejected their application for their experimental drug for the treatment of osteoarthritis pain, citing safety risks and an inadequate plan to manage them. Pfizer also reported that it has started clinical trials of its COVID-19 vaccine with children. Pfizer shares slipped 0.1% to $35.66 in after-hours trading, while Eli Lilly shares fell 0.1% to $183.00 in the after-hours trading session.</li>\n</ul>\n<ul>\n <li><b>Co-Diagnostics Inc</b> (NASDAQ:CODX) reported downbeat earnings for its fourth quarter on Thursday. Co-Diagnostics shares dropped 7.1% to $11.26 in the after-hours trading session.</li>\n <li><b>Gan Ltd</b> (NASDAQ:GAN) reported weaker-than-expected results for its fourth quarter, but issued strong sales forecast. Gan shares declined 9% to $21.04 in after-hours trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GAN":"GAN Limited","LLY":"礼来","PFE":"辉瑞","CODX":"Co-diagnostics Inc.","PRGS":"Progress Software Corporation"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2122420974","content_text":"Some of the stocks that may grab investor focus today are:\n\nProgress Software Corp (NASDAQ:PRGS) reported better-than-expected results for its first quarter and raised its FY21 guidance. Progress Software shares climbed 2.6% to $42.90 in the after-hours trading session.\nPfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) disclosed that an expert panel of the U.S. Food and Drug Administration has rejected their application for their experimental drug for the treatment of osteoarthritis pain, citing safety risks and an inadequate plan to manage them. Pfizer also reported that it has started clinical trials of its COVID-19 vaccine with children. Pfizer shares slipped 0.1% to $35.66 in after-hours trading, while Eli Lilly shares fell 0.1% to $183.00 in the after-hours trading session.\n\n\nCo-Diagnostics Inc (NASDAQ:CODX) reported downbeat earnings for its fourth quarter on Thursday. Co-Diagnostics shares dropped 7.1% to $11.26 in the after-hours trading session.\nGan Ltd (NASDAQ:GAN) reported weaker-than-expected results for its fourth quarter, but issued strong sales forecast. Gan shares declined 9% to $21.04 in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":273,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":13,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/356198104"}
精彩评论